Legacy lab applications stifle QC transformation and block the path to the lab of the future. Yet global biopharmas are often wary of breaking with the status quo in case they replicate past IT failures.

This White Paper demonstrates that a rapid and small-scale 'learn and confirm' program is an effective alternative to a wholesale 'rip and replace'. It covers:

  • Why 'learn and confirm' is a better approach to deploying a modern LIMS
  • Key considerations when defining your IT strategy
  • Criteria for choosing target pilot locations and sites
  • KPIs for deciding how to scale across the global footprint
  • Managing your organization through change.

Learn how to modernize QC with Veeva LIMS.